Kyverna Therapeutics, Inc. Class Action
Robbins LLP is Investigating Allegations that Kyverna Therapeutics, Inc. (KYTK) Provided Investors with Misleading Information in Connection with its IPO Robbins LLP announces that a shareholder filed a class action against